Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to Temozolomide

Frontiers in Oncology
A Lo DicoL Ottobrini

Abstract

The activity of the transcription factor, hypoxia-inducible factor (HIF)-1α, is a common driver of a number of the pathways involved in the aggressiveness of glioblastomas (GBMs), and it has been suggested that the reduction in this activity observed, soon after the administration of temozolomide (TMZ), can be a biomarker of an early response in GBM models. As HIF-1α is a tightly regulated protein, studying the processes involved in its downregulation could shed new light on the mechanisms underlying GBM sensitivity or resistance to TMZ. The effect of HIF-1α silencing on cell responsiveness to TMZ was assessed in four genetically different human GBM cell lines by evaluating cell viability and apoptosis-related gene balance. LAMP-2A silencing was used to evaluate the contribution of chaperone-mediated autophagy (CMA) to the modulation of HIF-1α activity in TMZ-sensitive and TMZ-resistant cells. The results showed that HIF-1α but not HIF-2α activity is associated with GBM responsiveness to TMZ: its downregulation improves the response of TMZ-resistant cells, while blocking CMA-mediated HIF-1α degradation induces resistance to TMZ in TMZ-sensitive cells. These findings are in line with the modulation of crucial apoptosis-related g...Continue Reading

References

Jan 10, 2004·Cell Death and Differentiation·T KanzawaS Kondo
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Sep 8, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Giovanni Lucignani
Jul 16, 2008·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Mehmet Yasar KaynarTaner Tanriverdi
Aug 2, 2008·The New England Journal of Medicine·Patrick Y Wen, Santosh Kesari
Nov 26, 2008·International Journal of Cancer. Journal International Du Cancer·Takaaki ImamuraDaniel C Chung
Mar 7, 2009·Acta Physiologica Hungarica·J M AdamsZ H Németh
May 30, 2009·Journal of Cellular Biochemistry·Kai RuanGaoliang Ouyang
Apr 9, 2010·Brain : a Journal of Neurology·Sascha SeidelTill Acker
Sep 24, 2010·Acta Neuropathologica·Ghazaleh TabatabaiMichael Weller
Jun 4, 2011·Neuro-oncology·Wolfgang WickMichael Platten
Sep 14, 2011·Proceedings of the National Academy of Sciences of the United States of America·Carmen Chak-Lui WongGregg L Semenza
Nov 30, 2011·Current Molecular Pharmacology·Jihong ZhangTracey D Bradshaw
Apr 26, 2012·Molecular Cancer Therapeutics·Shinji KohsakaShinya Tanaka
Nov 6, 2012·Current Oncology Reports·Derek R Johnson, Evanthia Galanis
Mar 28, 2013·Current Neurology and Neuroscience Reports·Adam L CohenHoward Colman
Jun 12, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Olivia LanvinElizabeth Cohen-Jonathan-Moyal
Jul 25, 2013·Autophagy·João Vasco FerreiraPaulo Pereira
Sep 5, 2013·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·A Lo DicoL Ottobrini
Oct 11, 2013·OncoTargets and Therapy·Niklas ThonFriedrich-Wilhelm Kreth
Jan 10, 2014·Nature Reviews. Molecular Cell Biology·Guillermo MariñoGuido Kroemer
Mar 29, 2014·Breast Cancer : Basic and Clinical Research·Sebastian KugerCholpon S Djuzenova
Apr 10, 2014·Frontiers in Oncology·Harry R HaynesKathreena M Kurian
Apr 17, 2014·Molecular Medicine Reports·Yuhui ZouWeimin Wang
Mar 11, 2015·Therapeutic Advances in Medical Oncology·Sarah J Welsh, Pippa G Corrie
Mar 31, 2015·European Journal of Nuclear Medicine and Molecular Imaging·A Lo DicoL Ottobrini
Jun 30, 2015·Molecular Cell·Esperanza AriasAna María Cuervo
Nov 19, 2015·Acta Pharmaceutica Sinica. B·Georgina N Masoud, Wei Li
Feb 3, 2016·Journal of Experimental & Clinical Cancer Research : CR·Yuanliang YanZhicheng Gong
Apr 20, 2016·Experimental Cell Research·Jun-Hai TangSheng-Qing Lv

❮ Previous
Next ❯

Citations

Jul 12, 2019·Journal of Experimental & Clinical Cancer Research : CR·Zhi-Peng WenXiao-Ping Chen
May 22, 2020·Cancer Cell International·Paola PalumboBenedetta Cinque
Jan 1, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Sandipan DattaJames M Angelastro
Dec 15, 2020·Frontiers in Oncology·Bárbara Paranhos CoelhoMarilene Hohmuth Lopes
Feb 16, 2021·Frontiers in Molecular Biosciences·Christophe OlivierFrançois M Vallette
Feb 27, 2021·Frontiers in Aging Neuroscience·Jaione Auzmendi-Iriarte, Ander Matheu
Mar 7, 2021·International Journal of Molecular Sciences·Alessia Lo DicoLuisa Ottobrini
Mar 7, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Shalini Sundramurthi ChelliahIshwar Parhar
Jul 3, 2021·International Journal of Molecular Sciences·Sara Rosińska, Julie Gavard
Jul 6, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Mohammad MalekanFateme Sheida
Jul 25, 2021·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Wei WuHeike E Daldrup-Link
Jul 23, 2021·Journal of Cellular and Molecular Medicine·Shiqi KongZhenzhong Li
Aug 10, 2021·Journal of Cellular Biochemistry·Parveen KumarManisha Yadav
Nov 19, 2021·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·S Arab, F Hasannejad

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear translocation
PCR
ELISA
nuclear
PCRs
Transfection

Software Mentioned

Prism
GraphPad

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms